Pallas Capital Advisors LLC Purchases Shares of 1,994 Chemed Corporation $CHE

Key Points

• Pallas Capital Advisors purchased 1,994 Chemed shares valued at approximately $929,000 during the second quarter. Institutional investors collectively own 95.85% of the company.
• Chemed reported quarterly EPS of $6.06, exceeding estimates of $5.60, while revenue rose 8.8% year over year to $673.25 million.
• The company raised its quarterly dividend from $0.60 to $0.70 per share, although analysts maintain a consensus “Hold” rating with a $530.75 price target.

Pallas Capital Advisors LLC purchased a new stake in Chemed Corporation (NYSE:CHE - Free Report) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 1,994 shares of the company's stock, valued at approximately $929,000.

A number of other institutional investors also recently modified their holdings of CHE. Commonwealth Equity Services LLC grew its holdings in shares of Chemed by 3.1% during the fourth quarter. Commonwealth Equity Services LLC now owns 734 shares of the company's stock worth $314,000 after buying an additional 22 shares in the last quarter. Cim LLC lifted its stake in Chemed by 1.1% in the 3rd quarter. Cim LLC now owns 2,139 shares of the company's stock valued at $958,000 after acquiring an additional 24 shares in the last quarter. Eukles Asset Management boosted its position in Chemed by 0.4% during the 4th quarter. Eukles Asset Management now owns 6,056 shares of the company's stock worth $2,591,000 after acquiring an additional 25 shares during the last quarter. MassMutual Private Wealth & Trust FSB boosted its position in Chemed by 65.3% during the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 81 shares of the company's stock worth $38,000 after acquiring an additional 32 shares during the last quarter. Finally, EverSource Wealth Advisors LLC grew its stake in shares of Chemed by 9.4% during the 1st quarter. EverSource Wealth Advisors LLC now owns 406 shares of the company's stock worth $153,000 after acquiring an additional 35 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on CHE shares. Oppenheimer lifted their price objective on shares of Chemed from $500.00 to $590.00 and gave the company an "outperform" rating in a report on Friday, July 31st. Wall Street Zen upgraded shares of Chemed from a "hold" rating to a "strong-buy" rating in a report on Saturday, August 1st. Royal Bank Of Canada raised their target price on shares of Chemed from $436.00 to $548.00 and gave the company a "sector perform" rating in a research report on Thursday, July 30th. Bank of America reiterated a "neutral" rating on shares of Chemed in a research note on Wednesday, July 29th. Finally, Weiss Ratings raised shares of Chemed from a "hold (c-)" rating to a "hold (c)" rating in a research report on Friday, July 17th. One research analyst has rated the stock with a Buy rating and five have given a Hold rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $530.75.

Chemed Stock Up 0.9%

CHE stock opened at $529.93 on Wednesday. The company has a market cap of $6.93 billion, a price-to-earnings ratio of 26.62, a P/E/G ratio of 2.02 and a beta of 0.51. Chemed Corporation has a twelve month low of $365.20 and a twelve month high of $557.00. The business has a 50 day moving average price of $492.50 and a two-hundred day moving average price of $444.25. The company has a quick ratio of 0.89, a current ratio of 0.91 and a debt-to-equity ratio of 0.17.

Chemed (NYSE:CHE - Get Free Report) last announced its quarterly earnings data on Tuesday, July 28th. The company reported $6.06 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $5.60 by $0.46. The company had revenue of $673.25 million for the quarter, compared to analysts' expectations of $665.04 million. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The business's revenue was up 8.8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $4.27 EPS. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Analysts anticipate that Chemed Corporation will post 23.18 EPS for the current fiscal year.

Chemed Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, September 3rd. Shareholders of record on Monday, August 17th will be given a dividend of $0.70 per share. This represents a $2.80 annualized dividend and a yield of 0.5%. This is an increase from Chemed's previous quarterly dividend of $0.60. The ex-dividend date of this dividend is Monday, August 17th. Chemed's payout ratio is currently 12.05%.

Insider Buying and Selling at Chemed

In other Chemed news, Director Patrick P. Grace sold 190 shares of the stock in a transaction on Friday, July 31st. The shares were sold at an average price of $532.00, for a total value of $101,080.00. Following the completion of the sale, the director owned 3,533 shares in the company, valued at $1,879,556. This trade represents a 5.10% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Andrea R. Lindell sold 1,347 shares of Chemed stock in a transaction dated Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total transaction of $602,553.51. Following the completion of the transaction, the director directly owned 4,578 shares of the company's stock, valued at approximately $2,047,876.74. This trade represents a 22.73% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 3,537 shares of company stock worth $1,782,654 over the last quarter. 3.33% of the stock is currently owned by insiders.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source